Expert consensus on the design and implementation of clinical safety centralized monitoring study of Chinese medical injection.
- Author:
Jun-Hua ZHANG
1
;
Jing-Tian REN
2
;
Jing-Qing HU
3
;
Yan-Ming XIE
4
;
Hai-Bo SONG
2
;
Ming-Jun ZHU
5
;
Rui GAO
6
;
Zhong WANG
4
;
Wen-Ke ZHENG
1
;
Xue-Lin LI
5
;
Meng JIANG
7
;
Yu-Hong HUANG
8
;
Fang LU
6
;
Li-Yun HE
4
;
Wei-Xiong LIAN
9
;
Zhong-Qi YANG
10
;
Wei-An YUAN
11
;
Si-Yuan HU
12
;
Bao-He WANG
8
;
Wei-Liang WANG
6
;
De-Quan REN
13
;
Bo-Li ZHANG
1
;
null
;
null
Author Information
- Publication Type:Journal Article
- Keywords: Chinese medical injection; centralized monitoring; safety evaluation
- From: China Journal of Chinese Materia Medica 2017;42(1):6-9
- CountryChina
- Language:Chinese
- Abstract: Along with the increase of clinical application, the safety of traditional Chinese medicine gained more and more attentions. In particular, the safety evaluation of Chinese medical injections has become a mandatory task should be completed by pharmaceutical companies under the supervision of China Food and Drug Administration(CFDA). Due to the weak foundation of previous studies, the safety issues of Chinese medical injections have not been fully understood, and lack of scientific and rational risk management programs. Clinical safety centralized monitoring(CSCM) is an important method for post-market safety evaluation of Chinese medicine. Due to the lack of appropriate norms and procedures, the quality of similar research is uneven, and the results vary. Combined with practical experience with experts' suggestions, we developed this expert consensus on the design and implementation of CSCM from three stages (design, implementation and report) with 20 technical points, which will provide technical support for future CSCM studies.